• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session

    6/24/22 12:07:20 PM ET
    $AKUS
    $ANEB
    $AVYA
    $BHAT
    Specialty Chemicals
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKUS alert in real time by email

    Gainers

    • USA Truck, Inc. (NASDAQ:USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) jumped 78.2% to $3.10 after jumping 26% on Thursday. ToughBuilt Industries reported closing of $6 million public offering.
    • Benitec Biopharma Inc. (NASDAQ:BNTC) surged 67.6% to $1.24. Benitec Biopharma, last month, posted a Q3 loss of $0.40 per share.
    • Wrap Technologies, Inc. (NASDAQ:WRAP) gained 48% to $2.77 in possible anticipation of protests after the US Supreme Court overturned Roe vs Wade. The company develops policing solutions to law enforcement and security personnel.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) jumped 33% to $0.4230. Evofem Biosciences recently announced results of post hoc analysis of registrational Phase 3 AMPOWER trial.
    • Zendesk, Inc. (NYSE:ZEN) gained 27.5% to $73.88. Global investment firms Permira and Hellman & Friedman LLC agreed to takeover Zendesk in an all-cash transaction that values Zendesk at $10.2 billion.
    • Greenlane Holdings, Inc. (NASDAQ:GNLN) shares rose 22.4% to $0.3217 after the company said it has begun shipping previously-restricted electronic nicotine delivery systems via a USPS exemption.
    • Molecular Templates, Inc. (NASDAQ:MTEM) climbed 21.1% to $1.15.
    • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) surged 20.6% to $5.10. Anebulo Pharmaceuticals will announce topline data for ANEB-001 from an ongoing Phase 2 clinical trial for acute cannabinoid intoxication on Tuesday July 5, 2022.
    • Moving iMage Technologies, Inc. (NYSE:MITQ) jumped 17.6% to $1.2699 after the company announced a $1 million buyback.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) surged 16.1% to $1.02.
    • Bausch Health Companies Inc. (NYSE:BHC) jumped 15.8% to $8.42.
    • Dragon Victory International Limited (NASDAQ:LYL) gained 14.6% to $0.87.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) gained 14.5% to $3.31. The Florida Medicaid Pharmaceutical & Therapeutics Committee recently approved adding GIMOTI to its preferred drug list immediately.
    • Novonix Limited (NASDAQ:NVX) surged 13.8% to $6.89.
    • Celularity Inc. (NASDAQ:CELU) shares gained 13% to $4.00 after HC Wainwright initiated coverage on the stock with a Buy rating and announced a $15 price target.
    • Oceaneering International, Inc. (NYSE:OII) surged 12.6% to $9.94.
    • Royal Caribbean Cruises Ltd. (NYSE:RCL) gained 12.6% to $40.64 in sympathy with Carnival, which reported a 50% increase revenue from Q1 to Q2.
    • Akouos, Inc. (NASDAQ:AKUS) jumped 11.6% to $4.70.
    • WISeKey International Holding AG (NASDAQ:WKEY) gained 11.6% to $2.80.
    • Carnival Corporation (NYSE:CCL) gained 8.7% to $10.49 after the company provided a Q2 business update. Revenue increased by nearly 50% in Q2 of 2022 compared to Q1 2022.
    • Palatin Technologies, Inc. (NYSE:PTN) rose 7.8% to $0.3008. Palatin Technologies, last month, posted a Q3 loss of $0.03 per share.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) rose 7.7% to $2.94 after jumping 263% on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) rose 7% to $0.4900.


    Losers

    • JE Cleantech Holdings Limited (NASDAQ:JCSE) dropped 36% to $11.37.
    • Quotient Limited (NASDAQ:QTNT) fell 32.4% to $0.27 after the company priced an offering of 66,666,667 shares for aggregate gross proceeds of $20 million.
    • Universe Pharmaceuticals INC (NASDAQ:UPC) dropped 29.6% to $0.69.
    • Avaya Holdings Corp. (NYSE:AVYA) shares dipped 27.4% to $2.7290.
    • CalAmp Corp. (NASDAQ:CAMP) fell 25.8% to $5.33 after the company reported worse-than-expected Q1 adjusted EPS and sales results.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) fell 25% to $0.7501 after the company reported pricing of public offering of common stock.
    • Genius Group Limited (NYSE:GNS) dropped 19.5% to $7.70.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) dipped 17.9% to $1.01.
    • Phoenix Motor Inc. (NASDAQ:PEV) shares fell 14.5% to $5.68 after jumping around 14% on Thursday.
    • Pardes Biosciences, Inc. (NASDAQ:PRDS) dipped 14.5% to $3.6950.
    • Terran Orbital Corporation (NYSE:LLAP) declined 13.3% to $5.62.
    • Valneva SE (NASDAQ:VALN) fell 13.2% to $27.29. The Committee for Medicinal Products for Human Use of the European Medicines Agency recommended marketing authorization in Europe for the company's COVID-19 vaccine candidate for use as primary vaccination in people from 18 to 50 years of age.
    • LiveVox Holdings, Inc. (NASDAQ:LVOX) dropped 12.7% to $1.4750.
    • 22nd Century Group, Inc. (NASDAQ:XXII) fell 12.6% to $2.2450.
    • TDH Holdings, Inc. (NASDAQ:PETZ) declined 12.2% to $2.58.
    • Janux Therapeutics, Inc. (NASDAQ:JANX) dropped 11.7% to $11.92.
    • LendingTree, Inc. (NASDAQ:TREE) fell 9.4% to $49.71 after the company cut its Q2 revenue guidance.
    • MDJM Ltd (NASDAQ:MDJH) shares fell 7.8% to $1.89 after jumping around 29% on Thursday.
    Get the next $AKUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKUS
    $ANEB
    $AVYA
    $BHAT

    CompanyDatePrice TargetRatingAnalyst
    Palatin Technologies Inc.
    $PTN
    12/12/2025$60.00Buy
    Laidlaw
    Bausch Health Companies Inc.
    $BHC
    12/9/2025$8.00Equal Weight
    Barclays
    Palatin Technologies Inc.
    $PTN
    12/3/2025$50.00Buy
    Alliance Global Partners
    Janux Therapeutics Inc.
    $JANX
    11/18/2025Peer Perform
    Wolfe Research
    Carnival Corporation
    $CCL
    11/18/2025$37.00Overweight
    Wells Fargo
    Oceaneering International Inc.
    $OII
    11/3/2025$25.00 → $27.00Hold
    TD Cowen
    CAMP4 Therapeutics Corporation
    $CAMP
    10/2/2025$7.00Overweight
    Cantor Fitzgerald
    Janux Therapeutics Inc.
    $JANX
    9/17/2025$47.00Overweight
    Barclays
    More analyst ratings

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Laidlaw initiated coverage on Palatin Technologies with a new price target

    Laidlaw initiated coverage of Palatin Technologies with a rating of Buy and set a new price target of $60.00

    12/12/25 8:54:18 AM ET
    $PTN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on Bausch Health with a new price target

    Barclays initiated coverage of Bausch Health with a rating of Equal Weight and set a new price target of $8.00

    12/9/25 8:43:03 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Alliance Global Partners initiated coverage on Palatin Technologies with a new price target

    Alliance Global Partners initiated coverage of Palatin Technologies with a rating of Buy and set a new price target of $50.00

    12/3/25 7:47:15 AM ET
    $PTN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Suvretta Capital Management, Llc bought $1,903,133 worth of shares (144,223 units at $13.20) (SEC Form 4)

    4 - Benitec Biopharma Inc. (0001808898) (Issuer)

    12/29/25 7:31:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Suvretta Capital Management, Llc bought $538,972 worth of shares (46,141 units at $11.68) (SEC Form 4)

    4 - Benitec Biopharma Inc. (0001808898) (Issuer)

    12/22/25 7:45:03 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Paulson & Co. Inc. bought $15,625,000 worth of shares (2,500,000 units at $6.25) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    11/28/25 5:38:39 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    SEC Filings

    View All

    SEC Form FWP filed by Royal Caribbean Cruises Ltd.

    FWP - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Subject)

    2/12/26 5:08:47 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    SEC Form 10-Q filed by Anebulo Pharmaceuticals Inc.

    10-Q - Anebulo Pharmaceuticals, Inc. (0001815974) (Filer)

    2/12/26 4:30:45 PM ET
    $ANEB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Anebulo Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Anebulo Pharmaceuticals, Inc. (0001815974) (Filer)

    2/12/26 4:15:33 PM ET
    $ANEB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. Department of Commerce Increases Duties on Chinese Battery-Grade Graphite to 160%+ in Final Determinations

    CHATTANOOGA, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ:NVX, ASX: NVX)) ("NOVONIX" or the "Company"), today acknowledged the U.S. Department of Commerce's ("Commerce") final determinations in the antidumping and countervailing duty investigations covering anode active materials ("AAM") imported into the U.S. from China. The total amount of the tariffs applicable to AAM imported from China will be at least 160%, subject to a final affirmative determination by the U.S. International Trade Commission ("ITC") that the U.S. AAM industry has been materially impeded because of Chinese AAM imports. The ITC's final determination is expected in March 2026. HighlightsSubject to

    2/12/26 6:32:06 PM ET
    $NVX
    Industrial Machinery/Components
    Miscellaneous

    Royal Caribbean Group announces pricing of $1.25 billion senior unsecured notes due 2033 and $1.25 billion senior unsecured notes due 2038

    MIAMI, Feb. 12, 2026 /PRNewswire/ -- Royal Caribbean Cruises Ltd. (NYSE:RCL) (the "Company") today announced that it has priced a registered public offering of $1.25 billion aggregate principal amount of 4.750% senior unsecured notes due 2033 (the "2033 Notes") and $1.25 billion aggregate principal amount of 5.250% senior unsecured notes due 2038 (the "2038 Notes" and, together with the 2033 Notes, the "Notes"). The 2033 Notes will mature on May 15, 2033 and the 2038 Notes will mature on February 27, 2038. The Notes are expected to be issued on or around February 27, 2026, subject to the satisfaction of customary closing conditions.

    2/12/26 5:03:00 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates

    Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or "Anebulo"), today announced financial results for the three months ended December 31, 2025, and recent updates. Second Quarter Fiscal Year 2026 and Subsequent Highlights: On February 6, 2026, Anebulo announced that the Company's board of directors (the "Board") approved the voluntary delisting of the Company's common stock from The Nasdaq Capital Market ("Nasdaq") and the subsequent voluntary deregistration of its common stock with the U.S. Securities and Exchange Commission ("SEC") in order to t

    2/12/26 4:15:00 PM ET
    $ANEB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Pujol Henry L was granted 11,357 shares and covered exercise/tax liability with 4,202 shares, increasing direct ownership by 97% to 14,509 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:07:03 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    President & CEO Liberty Jason T was granted 296,251 shares and covered exercise/tax liability with 111,299 shares, increasing direct ownership by 148% to 309,732 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:06:05 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    SVP, CLO, Secretary & CCO Lake Robert Alexander was granted 30,510 shares and covered exercise/tax liability with 11,586 shares, increasing direct ownership by 97% to 38,449 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:04:49 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    Leadership Updates

    Live Leadership Updates

    View All

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. ("WISeSat") specialized in space-technology and secure satellite communications for IoT applications, effective February 2, 2026. Of note, in November 2025, WISeSat announced a Business Combination Agreement with Columbus Acquisition Corp.

    2/10/26 1:00:00 AM ET
    $CODA
    $COLA
    $LAES
    Industrial Machinery/Components
    Industrials
    Semiconductors
    Technology

    Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer

    Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies based on its proprietary Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms, today announced that William Go, M.D., Ph.D., has been appointed Chief Medical Officer, effective January 26, 2026. Dr. Go succeeds Zachariah McIver, D.O., Ph.D., who will be leaving the Company to pursue other opportunities. Dr. Go brings more than 20 years of hematology and oncology experience, leading programs from early clinical development through pivotal trials, global regulatory approvals, and first-i

    1/26/26 7:00:00 AM ET
    $JANX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    WISeKey and Partners Present the Human-AI-T Manifesto to at Davos 2026 during the WISeKey Event

    WISeKey and Partners Present the Human-AI-T Manifesto at Davos 2026 during the WISeKey Event Ensuring Human Control, Trust, and Values in the Age of AGI and Quantum Computing For more information visit: https://www.wisekey.com/embedding-human-values-into-ai/ Davos, Switzerland, January 19, 2026 – WISeKey International Holding Ltd ("WISeKey") ((SIX: WIHN, NASDAQ:WKEY), a leading global cybersecurity, blockchain, and IoT company, today announces that in collaborations with its partners, gathered at the WISeKey Davos Event, will formally present the Human-AI-T (Human – Artificial Intelligence – Trust) Manifesto, a global framework designed to safeguard human sovereignty, trust, and ethical g

    1/19/26 1:00:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    Financials

    Live finance-specific insights

    View All

    Royal Caribbean Group Raises Dividend Fifty Percent

    MIAMI, Feb. 10, 2026 /PRNewswire/ -- The Board of Directors of Royal Caribbean Group (NYSE:RCL) today declared a quarterly dividend of $1.50 per common share payable on April 3, 2026 to shareholders of record at the close of business on March 6, 2026.  "This dividend increase reflects the continued strength of our business and the momentum across our global vacation portfolio," said Jason Liberty, President and CEO. "This step underscores our commitment to delivering meaningful returns to our shareholders while continuing to invest in the innovations and experiences that defin

    2/10/26 4:30:00 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    ROYAL CARIBBEAN GROUP REPORTS 2025 RESULTS, ISSUES 2026 GUIDANCE

    Fourth quarter exceeds guidance, resulting in over 30% earnings growth in 2025 WAVE season off to a record start, propelling momentum for 2026 Adjusted EPS in 2026 are expected to be $17.70 to $18.10 Expanding vacation portfolio with Royal Caribbean's new Discovery Class, and 10 additional ships for Celebrity River Cruises MIAMI, Jan. 29, 2026 /PRNewswire/ -- Royal Caribbean Group (NYSE: RCL) today reported 2025 Earnings per Share ("EPS") of $15.61 and Adjusted EPS of $15.64. These results were better than the company's guidance primarily due to more favorable revenue and better performance from joint ventures. Looking ahead, demand remains strong and the company expects Adjusted EPS to be i

    1/29/26 6:30:00 AM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    $AKUS
    $ANEB
    $AVYA
    $BHAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Benitec Biopharma Inc.

    SC 13G/A - Benitec Biopharma Inc. (0001808898) (Subject)

    12/6/24 1:47:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Molecular Templates Inc.

    SC 13G/A - Molecular Templates, Inc. (0001183765) (Subject)

    11/18/24 9:49:56 PM ET
    $MTEM
    Biotechnology: Pharmaceutical Preparations
    Health Care